Recombinant EIF2A anticorps (pSer51)

N° du produit ABIN5708157

L’anticorps anti-EIF2A Monoclonal Lapin est utilisé pour la détection de EIF2A dans des échantillons de Humain. Il a été validé pour WB et IHC.

Aperçu rapide pour Recombinant EIF2A anticorps (pSer51) (ABIN5708157)

Antigène: EIF2A (Eukaryotic Translation Initiation Factor 2A, 65kDa (EIF2A))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp EIF2A est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC)

Clone: RM298

Détail du produit anti-EIF2A anticorps

Épitope: pSer51

Fonction: Recombinant phospho-EIF2 alpha Antibody (Ser51)

Homologie: Mouse,Rat

Purification: Protein A purified from animal origin-free supernatant

Immunogène: A peptide corresponding the the amino acids surrounding phosphorylated serine 51 was used as the immunogen for the recombinant phospho-EIF2 alpha antibody.

Isotype: IgG

Information d'application

Indications d'application: The stated application concentrations are suggested starting points. Titration of the recombinant phospho-EIF2 alpha antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Antibody in PBS with 50 % glycerol, 1 % BSA and 0.09 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store the recombinant phospho-EIF2 alpha antibody at -20oC.

Détails sur EIF2A

Antigène: EIF2A (Eukaryotic Translation Initiation Factor 2A, 65kDa (EIF2A))

Autre désignation: EIF2A

Sujet: Eukaryotic initiation factor 2 alpha (EIF2 alpha), encoded by the EIF2S1 gene, is a central regulator of translation initiation and a key mediator of cellular stress responses. Phospho-EIF2 alpha Antibody, clone RM298, is designed to detect EIF2 alpha phosphorylated at serine 51 (pS51), a critical regulatory site that controls global protein synthesis and activation of stress response pathways.

Phosphorylation of EIF2 alpha at Ser51 represents a pivotal switch in translational control. Under normal conditions, EIF2 alpha functions as part of the heterotrimeric eIF2 complex, delivering initiator methionyl-tRNA to the ribosome during early stages of protein synthesis. However, when Ser51 is phosphorylated, this process is inhibited, leading to a rapid reduction in global protein translation. This allows cells to conserve energy and resources while selectively translating stress-response genes that promote survival and adaptation.

The phosphorylation of EIF2 alpha is mediated by a family of stress-responsive kinases, including PERK, PKR, GCN2, and HRI. Each kinase is activated by distinct stimuli such as endoplasmic reticulum stress, viral infection, oxidative stress, or amino acid deprivation. Through these pathways, EIF2 alpha serves as a convergence point for multiple signaling networks, coordinating the integrated stress response and enabling cells to adapt to adverse conditions.

Unlike total EIF2 alpha detection, which reflects overall protein levels, phospho-specific detection at Ser51 provides direct insight into pathway activation and translational repression. Increased phosphorylation at this site is commonly observed following treatment with stress-inducing agents or phosphatase inhibitors such as Calyculin A, which enhance accumulation of the phosphorylated form. As a result, phospho-EIF2 alpha is widely used as a sensitive marker of cellular stress signaling and translational shutdown.

Subcellularly, phosphorylated EIF2 alpha is predominantly localized in the cytoplasm, where it associates with ribosomes and translation initiation complexes. Under stress conditions, it is also linked to the formation of stress granules and other ribonucleoprotein assemblies involved in mRNA storage and regulation. These structures reflect a shift from active translation to selective mRNA handling and are a hallmark of stress-induced translational control.

Dysregulation of EIF2 alpha phosphorylation has been implicated in a range of diseases, including cancer, neurodegenerative disorders, and metabolic conditions. Sustained activation of this pathway can promote tumor cell survival under hypoxic or nutrient-limited conditions, while aberrant signaling contributes to impaired protein homeostasis in neurodegeneration. Monitoring phosphorylation at Ser51 therefore provides important insight into disease mechanisms and cellular adaptation.

Phospho-EIF2 alpha Antibody, clone RM298, enables selective detection of the activated, phosphorylated form of EIF2 alpha, supporting studies of stress signaling, translational regulation, and cellular response to environmental or pharmacological stimuli. Its ability to distinguish between inactive and active states of EIF2 alpha makes it a valuable tool for investigating pathway activation and dynamic changes in protein synthesis.

UniProt: P05198

Pathways: Ribonucleoprotein Complex Subunit Organization, ER-Nucleus Signaling, Hepatitis C, Methionine Biosynthetic Process, Ribosome Assembly